Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 180

1.

Intravenous Lacosamide in refractory nonconvulsive status epilepticus.

Mnatsakanyan L, Chung JM, Tsimerinov EI, Eliashiv DS.

Seizure. 2012 Apr;21(3):198-201. doi: 10.1016/j.seizure.2011.12.008. Epub 2012 Jan 11.

2.

Factors influencing response to intravenous lacosamide in emergency situations: LACO-IV study.

Garcés M, Villanueva V, Mauri JA, Suller A, García C, López González FJ, Rodríguez Osorio X, Fernández Pajarín G, Piera A, Guillamón E, Santafé C, Castillo A, Giner P, Torres N, Escalza I, Del Villar A, García de Casasola MC, Bonet M, Noé E, Olmedilla N.

Epilepsy Behav. 2014 Jul;36:144-52. doi: 10.1016/j.yebeh.2014.05.015. Epub 2014 Jun 10.

PMID:
24922617
3.

Usefulness of intravenous lacosamide in status epilepticus.

Santamarina E, Toledo M, Sueiras M, Raspall M, Ailouti N, Lainez E, Porta I, De Gracia R, Quintana M, Alvarez-Sabín J, Xavier Salas Puig XS.

J Neurol. 2013 Dec;260(12):3122-8.

PMID:
24122063
4.

Safety and efficacy of intravenous lacosamide for adjunctive treatment of refractory status epilepticus: a comparative cohort study.

Sutter R, Marsch S, Rüegg S.

CNS Drugs. 2013 Apr;27(4):321-9. doi: 10.1007/s40263-013-0049-y.

PMID:
23533010
5.

Intravenous lacosamide in status epilepticus and seizure clusters.

Höfler J, Unterberger I, Dobesberger J, Kuchukhidze G, Walser G, Trinka E.

Epilepsia. 2011 Oct;52(10):e148-52. doi: 10.1111/j.1528-1167.2011.03204.x. Epub 2011 Jul 29.

6.

Intravenous lacosamide as treatment option in post-stroke non convulsive status epilepticus in the elderly: a proof-of-concept, observational study.

Belcastro V, Vidale S, Pierguidi L, Sironi L, Tancredi L, Striano P, Taborelli A, Arnaboldi M.

Seizure. 2013 Dec;22(10):905-7. doi: 10.1016/j.seizure.2013.07.011. Epub 2013 Aug 13.

7.

Efficacy and safety of intravenous lacosamide in refractory nonconvulsive status epilepticus.

Koubeissi MZ, Mayor CL, Estephan B, Rashid S, Azar NJ.

Acta Neurol Scand. 2011 Feb;123(2):142-6. doi: 10.1111/j.1600-0404.2010.01430.x. Epub 2010 Oct 10.

PMID:
21198444
8.

Intravenous lacosamide in refractory seizure clusters and status epilepticus: comparison of 200 and 400 mg loading doses.

Legros B, Depondt C, Levy-Nogueira M, Ligot N, Mavroudakis N, Naeije G, Gaspard N.

Neurocrit Care. 2014 Jun;20(3):484-8. doi: 10.1007/s12028-013-9882-6.

PMID:
23896816
9.

Treatment of Recurrent Electrographic Nonconvulsive Seizures (TRENdS) study.

Husain AM.

Epilepsia. 2013 Sep;54 Suppl 6:84-8. doi: 10.1111/epi.12287.

10.

Efficacy of intravenous lacosamide as an add-on treatment in refractory status epilepticus: a multicentric prospective study.

Miró J, Toledo M, Santamarina E, Ricciardi AC, Villanueva V, Pato A, Ruiz J, Juvany R, Falip M.

Seizure. 2013 Jan;22(1):77-9. doi: 10.1016/j.seizure.2012.10.004. Epub 2012 Nov 3.

11.

Efficacy of intravenous lacosamide in refractory nonconvulsive status epilepticus and simple partial status epilepticus.

Rantsch K, Walter U, Wittstock M, Benecke R, Rösche J.

Seizure. 2011 Sep;20(7):529-32. doi: 10.1016/j.seizure.2011.03.010. Epub 2011 Apr 12.

12.

Safety and efficacy of lacosamide in the intensive care unit.

Cherry S, Judd L, Muniz JC, Elzawahry H, LaRoche S.

Neurocrit Care. 2012 Apr;16(2):294-8. doi: 10.1007/s12028-011-9662-0.

PMID:
22203547
13.

Intravenous lacosamide or phenytoin for treatment of refractory status epilepticus.

Kellinghaus C, Berning S, Stögbauer F.

Acta Neurol Scand. 2014 May;129(5):294-9. doi: 10.1111/ane.12174. Epub 2013 Aug 13.

PMID:
23937330
14.

Lacosamide in children with refractory status epilepticus. A multicenter Italian experience.

Grosso S, Zamponi N, Bartocci A, Cesaroni E, Cappanera S, Di Bartolo R, Balestri P.

Eur J Paediatr Neurol. 2014 Sep;18(5):604-8. doi: 10.1016/j.ejpn.2014.04.013. Epub 2014 Apr 24.

PMID:
24836405
15.

Intravenous lacosamide--an effective add-on treatment of refractory status epilepticus.

Albers JM, Möddel G, Dittrich R, Steidl C, Suntrup S, Ringelstein EB, Dziewas R.

Seizure. 2011 Jun;20(5):428-30. doi: 10.1016/j.seizure.2011.01.017. Epub 2011 Feb 26.

16.

Intravenous lacosamide for treatment of status epilepticus.

Kellinghaus C, Berning S, Immisch I, Larch J, Rosenow F, Rossetti AO, Tilz C, Trinka E.

Acta Neurol Scand. 2011 Feb;123(2):137-41. doi: 10.1111/j.1600-0404.2010.01423.x. Epub 2010 Sep 26.

PMID:
20868429
17.

Adjunctive lacosamide in clinical practice: sodium blockade with a difference?

Stephen LJ, Kelly K, Parker P, Brodie MJ.

Epilepsy Behav. 2011 Nov;22(3):499-504. doi: 10.1016/j.yebeh.2011.07.035. Epub 2011 Sep 3.

PMID:
21890421
18.

Status epilepticus developing during lacosamide monotherapy.

Papacostas SS.

BMJ Case Rep. 2015 Jan 27;2015. pii: bcr2014206354. doi: 10.1136/bcr-2014-206354.

PMID:
25628098
19.

Adjunctive lacosamide--5 years' clinical experience.

Stephen LJ, Kelly K, Parker P, Brodie MJ.

Epilepsy Res. 2014 Oct;108(8):1385-91. doi: 10.1016/j.eplepsyres.2014.06.018. Epub 2014 Jul 6.

PMID:
25064538
20.

Lacosamide as a new treatment option in status epilepticus.

Höfler J, Trinka E.

Epilepsia. 2013 Mar;54(3):393-404. doi: 10.1111/epi.12058. Epub 2013 Jan 7. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk